Literature DB >> 17207034

Clinical differentiation of atypical pneumonia using Japanese guidelines.

Tadashi Ishida1, Naoyuki Miyashita, Chikara Nakahama.   

Abstract

BACKGROUND AND
OBJECTIVE: Atypical pneumonia occupies an important position in community-acquired pneumonia. The aim of this study was to examine whether making a diagnosis of atypical pneumonia is possible based upon the Japanese Respiratory Society guidelines.
METHODS: The data from three prospective studies were reviewed. A total of 285 patients with mycoplasmal pneumonia or chlamydial pneumonia and 515 patients with pneumococcal pneumonia or Haemophilus influenzae pneumonia were assessed to determine whether these pneumonias met the diagnostic criteria for atypical pneumonia used in the Japanese Respiratory Society guidelines. The criteria were: (i) age less than 60 years; (ii) no or only minor underlying diseases; (iii) persistent cough; (iv) limited chest auscultatory findings; (v) no sputum, or no identified aetiological agent by rapid diagnosis; and (vi) a peripheral white blood cell count below 10,000/microL.
RESULTS: All items of the criteria proved to be valid except for 'age' in patients with Chlamydophila pneumoniae pneumonia using multiple regression analysis. The sensitivity and specificity for atypical pneumonia were 77.0% and 93.0% based on four or more of the criteria respectively.
CONCLUSION: Pure atypical pneumonia can be differentiated to some degree by clinical symptoms and laboratory findings. It is important to differentiate and treat bacterial pneumonia and atypical pneumonia in regions such as Japan, where Streptococcus pneumoniae resistance to macrolides is high. Treatment covering the two types of pneumonia should be considered in elderly patients and those with underlying respiratory disease.

Entities:  

Mesh:

Year:  2007        PMID: 17207034     DOI: 10.1111/j.1440-1843.2006.00927.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  17 in total

1.  Development and evaluation of a loop-mediated isothermal amplification method for the rapid detection of Chlamydophila pneumoniae.

Authors:  Y Kawai; N Miyashita; F Kishi; M Tabuchi; K Oda; T Yamaguchi; K Kawasaki; T Yamazaki; K Ouchi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-11       Impact factor: 3.267

2.  Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.

Authors:  N Miyashita; Y Kawai; T Yamaguchi; K Ouchi; M Oka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03       Impact factor: 3.267

3.  Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling.

Authors:  R C A de Groot; H Zhu; T Hoogenboezem; A C J M de Bruijn; E Eenjes; A E J 't Jong; A I Belo; S C Estevão; J J Bajramovic; R J Rottier; M Kool; A M C van Rossum; W W J Unger
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

4.  Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination.

Authors:  Naoyuki Miyashita; Yasushi Nakamori; Makoto Ogata; Naoki Fukuda; Akihisa Yamura; Yoshihisa Ishiura; Shosaku Nomura
Journal:  J Infect Chemother       Date:  2022-06-16       Impact factor: 2.065

5.  Community-acquired pneumonia and its predictors of mortality in rural southwestern Nigeria: A-five year retrospective observational study.

Authors:  Azeez Oyemomi Ibrahim; Olabode Muftau Shabi; Shuaib Kayode Aremu; Emmanuel Olusegun Omosanya; Fasanmi Tolulope Kolawole; Adewumi Oluwaserimi Ajetunmobi
Journal:  Afr J Emerg Med       Date:  2022-06-24

6.  Mycoplasma pneumonia: Clinical features and management.

Authors:  Surender Kashyap; Malay Sarkar
Journal:  Lung India       Date:  2010-04

7.  Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.

Authors:  Naoyuki Miyashita; Hiroto Akaike; Hideto Teranishi; Kazunobu Ouchi; Niro Okimoto
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

8.  Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays.

Authors:  Naoto Ishimaru; Satoshi Suzuki; Toshio Shimokawa; Yusaku Akashi; Yuto Takeuchi; Atsuo Ueda; Saori Kinami; Hisashi Ohnishi; Hiromichi Suzuki; Yasuharu Tokuda; Tetsuhiro Maeno
Journal:  Intern Emerg Med       Date:  2021-05-13       Impact factor: 3.397

9.  Combined Radiographic Features and Age Can Distinguish Mycoplasma pneumoniae Pneumonia from Other Bacterial Pneumonias: Analysis Using the 16S rRNA Gene Sequencing Data.

Authors:  Yuto Iwanaga; Kei Yamasaki; Kazuki Nemoto; Kentaro Akata; Hiroaki Ikegami; Keigo Uchimura; Shingo Noguchi; Chinatsu Nishida; Toshinori Kawanami; Kazumasa Fukuda; Hiroshi Mukae; Kazuhiro Yatera
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.241

10.  Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing.

Authors:  Naoyuki Miyashita; Tadaaki Sugiu; Yasuhiro Kawai; Keiko Oda; Tetsuya Yamaguchi; Kazunobu Ouchi; Yoshihiro Kobashi; Mikio Oka
Journal:  BMC Med Imaging       Date:  2009-04-29       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.